1M1K
Co-crystal structure of azithromycin bound to the 50S ribosomal subunit of Haloarcula marismortui
Summary for 1M1K
Entry DOI | 10.2210/pdb1m1k/pdb |
Related | 1K73 1K8A 1K9M 1KC8 1KD1 |
Descriptor | 23S RRNA, RIBOSOMAL PROTEIN L10E, RIBOSOMAL PROTEIN L13, ... (37 entities in total) |
Functional Keywords | 50s, ribosome, azithromycin, macrolide, haloarcula |
Biological source | Haloarcula marismortui More |
Total number of polymer chains | 30 |
Total formula weight | 1458904.18 |
Authors | Hansen, J.L.,Ippolito, J.A.,Ban, N.,Nissen, P.,Moore, P.B.,Steitz, T.A. (deposition date: 2002-06-19, release date: 2002-07-19, Last modification date: 2024-02-14) |
Primary citation | Hansen, J.L.,Ippolito, J.A.,Ban, N.,Nissen, P.,Moore, P.B.,Steitz, T.A. The structures of four macrolide antibiotics bound to the large ribosomal subunit. Mol.Cell, 10:117-128, 2002 Cited by PubMed Abstract: Crystal structures of the Haloarcula marismortui large ribosomal subunit complexed with the 16-membered macrolide antibiotics carbomycin A, spiramycin, and tylosin and a 15-membered macrolide, azithromycin, show that they bind in the polypeptide exit tunnel adjacent to the peptidyl transferase center. Their location suggests that they inhibit protein synthesis by blocking the egress of nascent polypeptides. The saccharide branch attached to C5 of the lactone rings extends toward the peptidyl transferase center, and the isobutyrate extension of the carbomycin A disaccharide overlaps the A-site. Unexpectedly, a reversible covalent bond forms between the ethylaldehyde substituent at the C6 position of the 16-membered macrolides and the N6 of A2103 (A2062, E. coli). Mutations in 23S rRNA that result in clinical resistance render the binding site less complementary to macrolides. PubMed: 12150912DOI: 10.1016/S1097-2765(02)00570-1 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (3.2 Å) |
Structure validation
Download full validation report
